Sanofi - Aventis Groupe: Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements

Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements Modification of existing collaboration agreement with AstraZeneca gives Sanofi full commercial control of nirsevimab

Related Keywords

United States ,Paris ,France General ,France ,Sandrine Guendoul ,Evan Berland ,Tarik Elgoutni ,Felix Lauscher ,Corentine Driancourt ,Eva Schaefer Jansen ,Nathalie Pham ,European Union ,Euronext ,Nasdaq ,Astrazeneca ,Collaboration Agreement ,Private Securities Litigation Reform Act ,Statement Regarding Forward Looking ,Sanofi ,Eventis ,Roupe ,Dress ,Release ,Nirsevimab ,Gobi ,Simplify ,Contractual ,Agreements ,